Your browser doesn't support javascript.
loading
Uncovering a Genetic Diagnosis in a Pediatric Patient by Whole Exome Sequencing: A Modeling Investigation in Wiedemann-Steiner Syndrome.
di Bari, Ighli; Ceccarini, Caterina; Curcetti, Maria; Cesarano, Carla; Croce, Anna-Irma; Adipietro, Iolanda; Gallicchio, Maria Grazia; Palladino, Grazia Pia; Patrizio, Maria Pia; Frisoli, Benedetta; Santacroce, Rosa; D'Apolito, Maria; D'Andrea, Giovanna; Castriota, Ombretta Michela; Pierri, Ciro Leonardo; Margaglione, Maurizio.
Afiliación
  • di Bari I; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Ceccarini C; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Curcetti M; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Cesarano C; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Croce AI; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Adipietro I; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Gallicchio MG; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Palladino GP; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Patrizio MP; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Frisoli B; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Santacroce R; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • D'Apolito M; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • D'Andrea G; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
  • Castriota OM; Neuropsychiatry for Child and Adolescent Unit, Department of Woman and Child, Policlinico Riuniti, 71122 Foggia, Italy.
  • Pierri CL; Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.
  • Margaglione M; Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
Genes (Basel) ; 15(9)2024 Sep 01.
Article en En | MEDLINE | ID: mdl-39336746
ABSTRACT

Background:

Wiedemann-Steiner syndrome (WSS), a rare autosomal-dominant disorder caused by haploinsufficiency of the KMT2A gene product, is part of a group of disorders called chromatinopathies. Chromatinopathies are neurodevelopmental disorders caused by mutations affecting the proteins responsible for chromatin remodeling and transcriptional regulation. The resulting gene expression dysregulation mediates the onset of a series of clinical features such as developmental delay, intellectual disability, facial dysmorphism, and behavioral disorders. Aim of the Study The aim of this study was to investigate a 10-year-old girl who presented with clinical features suggestive of WSS.

Methods:

Clinical and genetic investigations were performed. Whole exome sequencing (WES) was used for genetic testing, performed using Illumina technology. The bidirectional capillary Sanger resequencing technique was used in accordance with standard methodology to validate a mutation discovered by WES in all family members who were available. Utilizing computational protein modeling for structural and functional studies as well as in silico pathogenicity prediction models, the effect of the mutation was examined.

Results:

WES identified a de novo heterozygous missense variant in the KMT2A gene KMT2A(NM_001197104.2) c.3451C>G, p.(Arg1151Gly), absent in the gnomAD database. The variant was classified as Likely Pathogenetic (LP) according to the ACMG criteria and was predicted to affect the CXXC-type zinc finger domain functionality of the protein. Modeling of the resulting protein structure suggested that this variant changes the protein flexibility due to a variation in the Gibbs free energy and in the vibrational entropy energy difference between the wild-type and mutated domain, resulting in an alteration of the DNA binding affinity.

Conclusions:

A novel and de novo mutation discovered by the NGS approach, enhancing the mutation spectrum in the KMT2A gene, was characterized and associated with WSS. This novel KMT2A gene variant is suggested to modify the CXXC-type zinc finger domain functionality by affecting protein flexibility and DNA binding.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: N-Metiltransferasa de Histona-Lisina / Proteína de la Leucemia Mieloide-Linfoide / Secuenciación del Exoma Límite: Child / Female / Humans Idioma: En Revista: Genes (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: N-Metiltransferasa de Histona-Lisina / Proteína de la Leucemia Mieloide-Linfoide / Secuenciación del Exoma Límite: Child / Female / Humans Idioma: En Revista: Genes (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Italia